At this time There is only a recognized vaccine against tuberculosis, which is the most dangerous disease in the worldAnd over 100 years of age; By 2028, it could be replaced by a Spaniards who proven 50 % of children, and only adults, but needed 22 million investments.
Espean Rodriguez, a researcher at the University of Zarakosa and Estepan Rodriguez, CEO, said this in a speech with the media after participating in a day hosted by the Ministry of Health to calculate the advances of his vaccine and MDBweake.
Mtbvac before, in the shape began to take 90s, when the multi -tuberculosis unleashed in Malaga He gave the decisive path to Martin, a microbialist created at the Pastor Institute.
Today, clinical trials are already in their final stages, 3 for newborns and 2b for adults and 2B and the best candidate – the world’s performance studies are in advanced stages – to replace PCG (Calmet and Kurin), to be prepared in 1920.
Vaccized for more than 4,000 children one day
The main difference between its century pioneers is the BCG. It only protects the child from spreading the spread, which is very serious, but it is useless in adolescents and adultsThey produce respiratory or pulmonary tuberculosis, which are very frequent and spread.
Since 2022, medical tests have been launched in South Africa, Senegal and Madagascar, and more than 4,000 newborn people have been vaccinated with MTBVAC. The idea is to reach 7,500, for which they calculate two years, and two followers.
The rest of the 4,200 adolescents and adults in South Africa, Kenya and Tanzania has not yet been published, but the results of Ghang 2A are “vaccine safe and not infected with tuberculosis,” the researcher says. In India, the 3rd phase is set to start with about 30,000 adults and adolescents.
“If everything is going well,” says his partner, 2028 The date they set on the horizon Thus your vaccine has exceeded all regulatory procedures, which allows its commercialization by 2029.
